Fresenius Medical Care AG & Co KGaA ADR buy Societe Generale
Start price
17.11.23
/
50%
€17.70
Target price
17.11.24
-
Performance (%)
15.25%
End price
18.11.24
€20.40
Summary
This prediction ended on 18.11.24 with a price of €20.40. The prediction had a final performance of 15.25%. A total of €0.58 was paid as dividends for this prediction. Societe_Generale has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fresenius Medical Care AG & Co KGaA ADR | -1.554% | -1.554% | -9.524% |
| iShares Core DAX® | 0,23 % | -2,41 % | 15,34 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % | 31,09 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % | 43,63 % |
| iShares S&P 500 | 1,07 % | -1,58 % | 24,35 % |
Comments by Societe_Generale for this prediction
In the thread Fresenius Medical Care AG & Co KGaA ADR diskutieren
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) was upgraded by analysts at Societe Generale from a "hold" rating to a "buy" rating.
Ratings data for FMS provided by MarketBeat
In the thread Trading Fresenius Medical Care AG & Co KGaA ADR
Die von Societe_Generale gewählte maximale Laufzeit wurde überschritten